当前位置:首页 - 行情中心 - 金城医药(300233) - 财务分析 - 资产负债表

金城医药

(300233)

  

流通市值:57.40亿  总市值:59.58亿
流通股本:3.70亿   总股本:3.84亿

资产负债表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
流动资产:
  货币资金776,238,222.72825,798,100.6669,373,335753,869,136.82
  交易性金融资产180,000,00070,000,00072,000,000-
  衍生金融资产-20,987.16--
  应收票据及应收账款567,993,779.28566,278,606.95440,994,213.22489,177,566.93
  其中:应收票据23,910,206.4931,392,062.7121,096,39249,934,785.14
        应收账款544,083,572.79534,886,544.24419,897,821.22439,242,781.79
  应收款项融资165,655,892.1125,520,101.18139,746,625.88118,411,513.26
  预付款项28,272,985.6623,930,814.3330,309,818.6422,528,240.51
  其他应收款合计3,680,311.793,472,578.544,163,622.445,121,767.81
  存货446,540,224.09464,607,381.98528,473,986.7605,789,334.94
  其他流动资产6,374,111.676,205,853.569,674,485.3710,187,054.14
  流动资产合计2,174,755,527.312,085,834,424.31,894,736,087.252,005,084,614.41
非流动资产:
  长期股权投资18,328,931.2918,400,459.418,507,694.5418,870,502.34
  其他权益工具投资163,441,261.6163,441,261.6165,266,720.59162,511,500.47
  固定资产2,079,085,828.652,137,608,115.562,199,526,627.892,142,456,505.74
  在建工程8,994,262.353,362,026.3512,358,446.23116,208,742.07
  使用权资产6,597,663.287,126,048.967,684,733.886,579,168.73
  无形资产542,975,551.52545,609,701.21513,748,541.43518,075,671.31
  开发支出132,320,264.09138,861,588.64234,389,619.15233,284,205.05
  长期待摊费用8,557,931.929,119,615.189,892,890.4910,612,971.85
  递延所得税资产41,866,968.9147,602,189.3650,379,968.652,750,101.64
  其他非流动资产34,042,027.0633,926,241.5234,561,546.116,894,133.13
  非流动资产合计3,036,210,690.673,105,057,247.783,246,316,788.93,278,243,502.33
  资产总计5,210,966,217.985,190,891,672.085,141,052,876.155,283,328,116.74
流动负债:
  短期借款70,045,130.55120,076,880.56120,066,694.45114,070,413.9
  衍生金融负债128,103.96-1,679.8136,821.31
  应付票据及应付账款469,580,668.17498,187,495.69435,064,113.2542,259,754.82
  其中:应付票据155,280,241.63154,154,513.42103,161,408.02189,609,721.45
        应付账款314,300,426.54344,032,982.27331,902,705.18352,650,033.37
  合同负债107,514,448.4640,779,189.0431,619,414.7931,013,657.35
  应付职工薪酬157,690,426.3185,543,719.97181,629,373.25179,624,160.52
  应交税费41,497,965.7334,569,111.0530,126,542.4619,287,842.5
  其他应付款合计159,602,373.43170,694,612.62191,727,274.3198,461,019.86
  一年内到期的非流动负债244,791,292.54170,436,860.1991,668,278.155,640,465.15
  其他流动负债4,267,695.781,801,067.262,738,168.042,951,613.43
  流动负债合计1,255,118,104.921,222,088,936.381,084,641,538.451,093,345,748.84
非流动负债:
  长期借款17,477,78085,522,784.31163,335,174.97246,393,048.92
  租赁负债4,061,461.853,400,065.085,758,667.755,923,613.46
  预计负债--2,030,8002,030,800
  递延收益43,187,776.145,235,415.953,939,915.553,366,781.5
  递延所得税负债106,803,934.12110,678,705.01113,938,137.96117,995,518.47
  非流动负债合计171,530,952.07244,836,970.3339,002,696.18425,709,762.35
  负债合计1,426,649,056.991,466,925,906.681,423,644,234.631,519,055,511.19
所有者权益(或股东权益):
  实收资本(或股本)383,874,587383,874,587383,874,587383,874,587
  资本公积2,330,377,334.252,330,377,334.252,327,697,793.592,327,697,793.59
  减:库存股55,009,17055,009,17055,009,17055,009,170
  其他综合收益51,650,262.8751,650,262.8753,319,357.1151,252,942.02
  专项储备10,453,578.769,112,422.529,561,886.919,191,107.3
  盈余公积165,120,502.47165,120,502.47146,083,594146,083,594
  未分配利润836,054,180.15778,259,677.39784,687,404.82834,426,708.43
  归属于母公司股东权益合计3,722,521,275.53,663,385,616.53,650,215,453.433,697,517,562.34
  少数股东权益61,795,885.4960,580,148.967,193,188.0966,755,043.21
  股东权益合计3,784,317,160.993,723,965,765.43,717,408,641.523,764,272,605.55
  负债和股东权益合计5,210,966,217.985,190,891,672.085,141,052,876.155,283,328,116.74
公告日期2026-04-242026-03-272025-10-272025-08-21
审计意见(境内)标准无保留意见
TOP↑